100 related articles for article (PubMed ID: 2833038)
21. [Diagnostic value of bronchoalveolar lavage (BAL) in various diseases of the respiratory tract].
Lasota A; Grubek-Jaworska H; Barliński J; Droszcz W
Pol Tyg Lek; 1988 May; 43(21):674-80. PubMed ID: 3226973
[No Abstract] [Full Text] [Related]
22. Morphological and biochemical properties of alveolar fibroblasts in interstitial lung diseases.
Fireman E; Shahar I; Shoval S; Messer G; Dvash S; Grief J
Lung; 2001; 179(2):105-17. PubMed ID: 11733853
[TBL] [Abstract][Full Text] [Related]
23. [Use of flow cytometry in evaluation of cellular changes in interstitial lung diseases].
Kopiński P
Folia Med Cracov; 1997; 38(3-4):69-115. PubMed ID: 10481384
[TBL] [Abstract][Full Text] [Related]
24. [Value of the cytologic and biochemical study of alveolar lavage fluid in the evaluation of the developmental ability of sarcoidosis].
Leclerc P; Duchassaing D; Cambillau M; Capron F
Sem Hop; 1983 Jan; 59(4):227-31. PubMed ID: 6301050
[TBL] [Abstract][Full Text] [Related]
25. Subcellular localization of angiotensin-converting enzyme in the human alveolar macrophage.
Eklund A; Blaschke E; Danielsson B
Scand J Clin Lab Invest; 1987 Feb; 47(1):47-54. PubMed ID: 3033814
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of the analysis of broncho-alveolar lavage (BAL) cellular composition in diagnosis and monitoring of pulmonary sarcoidosis treatment.
Szklarz E
Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):133-40. PubMed ID: 2619497
[TBL] [Abstract][Full Text] [Related]
27. Features of bronchoalveolar lavage differentiating hypersensitivity pneumonitis and pulmonary sarcoidosis at time of initial presentation.
Cantin A; Bégin R; Boileau R; Drapeau G; Rola-Pleszczynski M
Clin Invest Med; 1984; 7(2):89-94. PubMed ID: 6467702
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin converting enzyme in bronchoalveolar lavage fluid in pulmonary sarcoidosis.
Perrin-Fayolle M; Pacheco Y; Harf R; Montagnon B; Biot N
Thorax; 1981 Oct; 36(10):790-2. PubMed ID: 6277031
[TBL] [Abstract][Full Text] [Related]
29. Bronchoalveolar lavage fluid granulomas in a case of severe sarcoidosis.
Hendricks MV; Crosby JH; Davis WB
Am J Respir Crit Care Med; 1999 Aug; 160(2):730-1. PubMed ID: 10430753
[TBL] [Abstract][Full Text] [Related]
30. Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases.
Reichenberger F; Schauer J; Kellner K; Sack U; Stiehl P; Winkler J
Lung; 2001; 179(3):163-74. PubMed ID: 11891606
[TBL] [Abstract][Full Text] [Related]
31. Activity of angiotensin I converting enzyme in sarcoidosis, atopic bronchial asthma and acute bronchitis.
Plusa T; Chcialowski A; Piechota W; Pirozyński M
Allergol Immunopathol (Madr); 1990; 18(4):217-21. PubMed ID: 2176061
[TBL] [Abstract][Full Text] [Related]
32. Procollagen III peptide in bronchoalveolar lavage fluid. A potential marker of altered collagen synthesis reflecting pulmonary disease in sarcoidosis.
Bjermer L; Thunell M; Hällgren R
Lab Invest; 1986 Dec; 55(6):654-6. PubMed ID: 3023750
[TBL] [Abstract][Full Text] [Related]
33. Asbestos bodies in bronchoalveolar lavage fluid. A study of 20 asbestos-exposed individuals and comparison to patients with other chronic interstitial lung diseases.
Roggli VL; Piantadosi CA; Bell DY
Acta Cytol; 1986; 30(5):470-6. PubMed ID: 3465136
[TBL] [Abstract][Full Text] [Related]
34. Alveolar lymphocytes in the follow-up of sarcoidosis.
Carreiro G; Rottoli P; Rottoli L; Perari MG
Allergol Immunopathol (Madr); 1984; 12(5):377-82. PubMed ID: 6240932
[TBL] [Abstract][Full Text] [Related]
35. [Vitronectin in bronchoalveolar lavage--a parameter of disease activity in sarcoidosis].
Pohl WR; Rennard SI; Micksche M; Umek H; Klech H; Kummer F; Köhn H
Wien Klin Wochenschr; 1993; 105(14):393-7. PubMed ID: 7690172
[TBL] [Abstract][Full Text] [Related]
36. Nonspecificity of elevated angiotensin-converting enzyme activity in bronchoalveolar lavage fluid from high permeability lung edema states.
Krieger B; Schwartz J; Loomis W; Marsh J; Spragg R
Am Rev Respir Dis; 1984 Mar; 129(3):499-500. PubMed ID: 6322628
[TBL] [Abstract][Full Text] [Related]
37. Extracellular matrix components in bronchoalveolar lavage fluid in sarcoidosis and their relationship to signs of alveolitis.
Blaschke E; Eklund A; Hernbrand R
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):1020-5. PubMed ID: 2327635
[TBL] [Abstract][Full Text] [Related]
38. Elevation of the bronchoalveolar concentration of angiotensin I converting enzyme in sarcoidosis.
Mordelet-Dambrine MS; Stanislas-Leguern GM; Huchon GJ; Baumann FC; Marsac JH; Chrétien J
Am Rev Respir Dis; 1982 Sep; 126(3):472-5. PubMed ID: 6289705
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-converting enzyme in serum and in bronchoalveolar lavage in sarcoidosis.
Gupta RG; Sicilian L; Catchatourian R; Bekerman C; Oparil S; Szidon JP
Respiration; 1982; 43(3):153-7. PubMed ID: 6287548
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of the prognosis in sarcoidosis: remission as an issue of biological criteria and current cellular activities (ACE and alveolar lymphocytosis)].
Dietemann-Molard A; De Blay F; Bohner C; Roegel E; Pauli G
Rev Mal Respir; 1990; 7(2):129-34. PubMed ID: 2157267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
